Urbana, Ill.-based Cancer Center at Illinois has earned designation as a basic laboratory cancer center from the National Cancer Institute. The center is now the eighth basic laboratory cancer center in the U.S., the first in Illinois and the first…
Oncology
Santa Monica, Calif.-based Providence Saint John’s Health Center — part of Renton, Wash.-based Providence — has received an estimated $100 million gift for cancer research, the largest philanthropic gift in the organization’s history. The gift will establish the Stanley H.…
New Hyde Park, N.Y.-based Northwell Health and the Northwell Cancer Institute have tapped Miguel Materin, MD, as system head of ocular oncology. As system head, Dr. Materin will establish a pediatric eye tumor program at Northwell’s Cohen Children’s Medical Center,…
Gastonia, N.C.-based CaroMont Health is investing $200 million to expand oncology services through three key projects. Four things to know: 1. The investment — the second largest in the system’s history — includes a new hematology and oncology physician office…
Sarasota (Fla.) Memorial Health Care System achieved a 75% early lung cancer diagnosis rate through its expanded detection program. The program uses AI to identify incidental findings documented in more than 430,000 radiology reports each year, according to an April…
Hackensack Meridian Hackensack (N.J.) University Medical Center is partnering with Teen Cancer America to expand the hospital’s adolescent and young adult program. The program treats patients ages 15-39 who have received a cancer diagnosis, and provides survival care to close…
Creating healthcare access is not about “squeezing the existing structure,” rather, it requires flipping the script on what access looks like, according to Jefferson Health President Baligh Yehia, MD. Jefferson Health is a Philadelphia-based, 33-hospital system with a lofty goal. “When…
For decades, a cancer patient’s access to cutting-edge therapies has been largely delimited by their proximity to an academic medical center. Recent advancements in clinical trial decentralization have begun to loosen that restriction. Between 2018 and 2019, HHS implemented a…
Liver cancer cases are expected to rise dramatically, primarily driven by metabolic dysfunction-associated steatotic liver disease, a recent study found. The study, published March 31 in Portal Hypertension & Cirrhosis, analyzed data from global cancer databases including GLOBOCAN 2022 and…
Baltimore-based University of Maryland Greenebaum Comprehensive Cancer Center received a $5.5 million donation to advance scientific research and cancer care. This gift comes from the Marlene and Stewart Greenebaum Family Foundation, according to an April 13 system news release. It…
